Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?

AIMS: Since the beginning of the COVID pandemic, studies reported an increase in children’s mental health issues and questioned the impact of SARS‐CoV‐2 on psychiatric symptoms. METHODS: We compared COVID seroconversion in children hospitalized with acute, severe psychiatric symptoms (n = 52) with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayrolles, Anaël, Ellul, Pierre, Trebossen, Vincent, Houhou‐Fidouh, Nadira, Bonacorsi, Stephane, Descamps, Diane, Delorme, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Micro Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216372/
https://www.ncbi.nlm.nih.gov/pubmed/35257512
http://dx.doi.org/10.1002/npr2.12236
Descripción
Sumario:AIMS: Since the beginning of the COVID pandemic, studies reported an increase in children’s mental health issues and questioned the impact of SARS‐CoV‐2 on psychiatric symptoms. METHODS: We compared COVID seroconversion in children hospitalized with acute, severe psychiatric symptoms (n = 52) with the sex‐ and age‐matched control group (n = 52) living in the same low‐income geographic area and sampled during the same time period. RESULTS: Contrary to our hypothesis, we observed less seroconverted children with psychiatric conditions 9.61% (95% CI, 3.59‐21.80) vs 34.61% (95% CI, 22.33‐49.16; χ (2) = 14.7, P = 1.24E−4; OR = 0.20; 95% CI, 0.05‐0.64). CONCLUSION: This suggests a lower direct impact of SARS‐CoV‐2 compared with the impact of mitigation strategies on psychiatric symptom deterioration in children reported since early stages of the pandemic.

Ejemplares similares